LASIK Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

LASIK (Laser-Assisted In Situ Keratomileusis) is the world's most commonly performed elective surgical procedure, with over 700,000 procedures performed annually in the United States alone and more than 40 million eyes treated worldwide since its FDA approval in 1999. It uses an excimer laser to precisely reshape the cornea — the clear front surface of the eye — so that incoming light focuses correctly on the retina, eliminating or significantly reducing the need for glasses or contact lenses.

The procedure corrects three primary refractive errors: myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. Modern LASIK platforms, including wavefront-guided (custom LASIK) and topography-guided systems, map the unique optical imperfections of each eye to deliver personalized corrections that can improve vision beyond what glasses or contacts achieve.

LASIK is performed by creating a thin flap in the outer corneal tissue using either a microkeratome blade or, more commonly today, a femtosecond laser (bladeless/all-laser LASIK). The flap is folded back, the underlying stroma is reshaped with the excimer laser, and the flap is repositioned, where it adheres naturally without sutures within minutes.

LASIK corrects refractive errors arising from the shape of the cornea or the length of the eyeball. Treatable conditions include:

• Myopia (nearsightedness): FDA-approved for corrections up to –12.00 diopters (D); most surgeons target up to –8.00 D for optimal outcomes. Caused by an overly curved cornea or elongated eyeball.
• Hyperopia (farsightedness): FDA-approved up to +6.00 D. Caused by a flat cornea or short eyeball; objects at all distances may appear blurred.
• Astigmatism: Up to ±6.00 D of cylinder. Caused by an irregularly shaped cornea or lens that produces multiple focal points, resulting in distorted or blurred vision.
• Mixed astigmatism: Myopia in one meridian and hyperopia in the other — treatable with topography-guided LASIK platforms.

LASIK does not treat presbyopia (age-related near vision loss), though monovision LASIK — correcting one eye for distance and one for near — can reduce dependence on reading glasses in suitable patients.

A comprehensive pre-operative evaluation by a qualified ophthalmologist determines LASIK candidacy. Ideal candidates meet all of the following criteria:

• Age 18 or older (most surgeons prefer 21+, as the prescription must be stable)
• Stable refraction for at least 12 months (no change greater than 0.50 D per year)
• Sufficient corneal thickness (minimum ~250 µm of residual stromal bed after ablation, minimum total corneal thickness typically ≥480 µm)
• No significant corneal disease (no keratoconus, pellucid marginal degeneration, or corneal scarring)
• Pupil size within acceptable range under scotopic conditions
• No active autoimmune or connective tissue disease that impairs healing
• No uncontrolled dry eye disease

Contraindications include: keratoconus or forme fruste keratoconus, corneal ectasia risk factors, thin corneas below the safe ablation threshold, unstable prescription, active ocular infection or inflammation, uncontrolled glaucoma, severe dry eye, and pregnancy or breastfeeding (hormonal changes alter refraction). Patients with these factors may be candidates for surface ablation (PRK/LASEK) or implantable collamer lens (ICL) instead.

Several laser vision correction platforms are available, each with specific advantages:

• Standard LASIK: Flap created by microkeratome blade; excimer laser performs ablation. Well-established safety record but increasingly replaced by all-laser approaches.
• Bladeless (All-Laser) LASIK / iLASIK: Femtosecond laser creates the corneal flap with greater precision and customizable depth and diameter. Reduces risk of flap-related complications. The current gold standard at most centers.
• Wavefront-Guided LASIK (Custom LASIK): Uses a wavefront aberrometer map of the eye's unique optical imperfections to program the excimer laser. Can correct higher-order aberrations beyond sphere and cylinder, potentially improving night vision quality and contrast sensitivity compared to standard treatment.
• Topography-Guided LASIK (Contoura Vision): FDA-approved in 2015. Programs the laser using corneal topography data, treating the curvature of the corneal surface. Clinical trials showed ~64% of treated patients achieved better than 20/20 uncorrected vision. Especially useful for irregular corneas.
• SMILE (Small Incision Lenticule Extraction): A newer flapless procedure where a femtosecond laser creates a disc-shaped lenticule within the cornea, which is then removed through a small arc-shaped incision. Approved for myopia up to –10.00 D. No flap means no flap-related complications; faster return of corneal biomechanical strength. Not yet FDA-approved for hyperopia.
• PRK / LASEK / TransPRK (Surface Ablation): No flap is created; the epithelium is removed, the stroma is treated, and the surface heals over 3–5 days. Slightly longer recovery than LASIK but recommended for thin corneas, active contact sports participants, or professions where eye trauma is a risk (military, martial arts).

The procedure itself takes approximately 5–10 minutes per eye. After numbing drops are applied, a lid speculum holds the eye open, a suction ring is applied, the flap is created, the laser ablation is performed (typically 30–60 seconds of laser time), and the flap is replaced. Patients are instructed to go home and rest for several hours.

LASIK consistently demonstrates excellent safety and efficacy in peer-reviewed literature and FDA studies:

• Rapid visual recovery: Most patients notice improved vision within hours; functional vision typically returns within 24–48 hours. Many return to work the next day.
• High efficacy: FDA-reviewed studies show 95–99% of patients achieve 20/40 (legal driving standard) or better uncorrected visual acuity; approximately 90% achieve 20/20 or better.
• Durability: Results are permanent in the treated range. The underlying refractive correction does not regress, though the natural development of presbyopia or cataracts with age remains unaffected.
• Enhanced quality of life: Studies published in the Journal of Cataract and Refractive Surgery consistently report high patient satisfaction rates exceeding 95%, with significant improvements in quality of life scores.
• Low enhancement rate: Approximately 2–5% of patients require an enhancement procedure for residual refractive error; this rate has declined with modern topography-guided platforms.
• Cost savings over time: Eliminating or reducing dependence on glasses and contacts delivers cumulative lifetime savings that often exceed the upfront surgical cost within 5–10 years.

LASIK is among the safest elective surgical procedures, but like all surgery it carries risks. Patients should have a thorough informed consent discussion with their surgeon. Documented risks include:

• Dry eye syndrome: The most common side effect, affecting 20–40% of patients in the early postoperative period. Corneal nerve severing during flap creation reduces tear reflex. Symptoms usually resolve within 6–12 months with lubricating drops; severe persistent dry eye occurs in approximately 1–2% of patients. Risk is higher in patients with pre-existing dry eye.
• Halos, starbursts, and glare: Related to the optical zone size relative to scotopic pupil diameter. Modern large-ablation-zone lasers have significantly reduced but not eliminated this complication. More commonly reported with early-generation ablation profiles.
• Undercorrection or overcorrection: Residual refractive error in approximately 5–10% of cases; most can be corrected with an enhancement procedure once the refraction stabilizes (3–6 months post-op).
• Regression: Gradual return of some refractive error, most commonly in high myopes. Enhancement is possible if sufficient corneal tissue remains.
• Corneal ectasia: A rare but serious complication (~0.04–0.6% of cases) in which the cornea progressively bulges and thins after surgery. Risk factors include thin corneas, abnormal topography, high corrections, and young age. Treatment includes corneal cross-linking; severe cases may require corneal transplantation. Careful pre-operative screening dramatically reduces this risk.
• Flap complications: Buttonhole flaps, incomplete flaps, flap displacement, or epithelial ingrowth (cells growing under the flap) — collectively occurring in less than 1% of cases with experienced surgeons using femtosecond laser flap creation.
• Infection / keratitis: Diffuse lamellar keratitis (DLK) or microbial keratitis occur rarely; incidence less than 0.1% with current protocols.
• Vision loss: Loss of two or more lines of best-corrected visual acuity occurs in less than 1% of cases and is more common in patients with pre-existing conditions such as irregular astigmatism or amblyopia.

The FDA notes that patient dissatisfaction is highest among those with dry eye, large pupils, high prescriptions, and unrealistic expectations. Selecting a qualified surgeon, undergoing comprehensive pre-operative testing, and having realistic discussions about outcomes substantially reduce the risk of adverse results.

Recovery from LASIK is generally rapid compared to other surgical procedures. A typical postoperative timeline includes:

• Immediately after surgery: Mild discomfort, tearing, light sensitivity, and blurred vision for 2–4 hours. Patients are instructed to rest with eyes closed. A follow-up visit is scheduled for the next day.
• Day 1 post-op: Vision is typically functional; most patients see well enough to drive (though this should be confirmed at the day-1 visit). Steroid and antibiotic eye drops are begun and continued for 1 week.
• Week 1: Avoid rubbing the eyes (this is critical — flap displacement can occur). Avoid swimming pools, hot tubs, and dusty environments. Lubricating drops used frequently to manage dryness.
• Weeks 2–4: Return to most physical activities. Protective eyewear recommended for contact sports for at least 1 month.
• 3 months: Refraction typically stabilizes. This is when enhancement eligibility is assessed if needed.
• Follow-up schedule: Day 1, week 1, month 1, month 3, month 6, year 1 — then annually. Regular follow-up with an ophthalmologist is recommended long-term to monitor for ectasia, dry eye, and to address future age-related changes (cataracts, presbyopia).

Patients should carry their operative report when seeing a new eye doctor, as the pre-operative corneal measurements are needed for accurate intraocular lens (IOL) power calculations if cataract surgery is required in the future.

LASIK pricing varies significantly based on multiple factors:

• Technology used: Standard LASIK is less expensive than bladeless, wavefront-guided, or topography-guided LASIK. All-laser LASIK typically costs 20–40% more than blade-based LASIK per eye.
• Geographic location: In the United States, LASIK costs $2,000–$3,000 per eye. In the United Kingdom, £1,500–£2,500 per eye. In India, LASIK ranges from ₹30,000–₹80,000 per eye (approximately $350–$950 USD), making it a popular medical tourism destination.
• Surgeon experience and reputation: Fellowship-trained refractive surgeons at academic centers typically charge more but may offer superior outcomes in complex cases.
• Pre-operative evaluation: Comprehensive testing (corneal topography, wavefront analysis, OCT pachymetry) may be billed separately at some centers.
• Included enhancements: Many centers offer lifetime enhancement guarantees — if vision regresses and sufficient corneal tissue remains, the enhancement is performed at no additional cost. Confirm whether this is included.
• Insurance coverage: LASIK is considered elective by most insurers in the US and is not covered under standard health plans. FSA and HSA funds can typically be used. In some countries with universal healthcare, coverage policies differ.

When evaluating price, distinguish between centers offering a single fee that includes all pre-op testing, the procedure, postoperative care, and enhancement guarantees versus those advertising low per-eye rates that exclude these components.

Not all patients are LASIK candidates. Several effective alternatives exist:

• PRK (Photorefractive Keratectomy): The original laser eye surgery. No flap is created; the epithelium is removed and regrows over 3–5 days. Similar final outcomes to LASIK but longer visual recovery (1–2 weeks). Preferred for patients with thin corneas or high-impact occupations.
• SMILE (Small Incision Lenticule Extraction): Flapless femtosecond-only procedure. Treats myopia and myopic astigmatism. Preserves more corneal biomechanical integrity than LASIK. Growing evidence base; not available at all centers.
• Implantable Collamer Lens (ICL / EVO ICL): A phakic intraocular lens implanted in front of the natural lens. Suitable for high myopia (up to –20.00 D), thin corneas, or dry eye contraindications to laser surgery. Reversible and preserves the natural corneal tissue. Higher upfront cost but preserves future options.
• Refractive Lens Exchange (RLE): Removal of the natural lens and replacement with a corrective IOL. Appropriate for patients over 45 with high refractive errors or early lens changes. Permanently eliminates cataract risk. Not reversible.
• Orthokeratology (Ortho-K): Rigid contact lenses worn overnight that temporarily reshape the cornea, providing clear vision during the day without lenses. No surgery; must be worn nightly for maintained effect. Used for myopia control in children.
• Glasses and contact lenses: Non-surgical management remains an effective, low-risk option for all refractive error magnitudes. Modern contact lens designs (silicone hydrogel, daily disposables) are safe when used as directed.